(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride
N-((1R,2R)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)octanamide ((2R,3R)-2,3-dihydroxysuccinate)(2:1)
(S)-Quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate
(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol
N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)octanamide
Glucosylceramide synthase-IN-1
N-(4-(2-Hydroxypropan-2-yl)phenyl)-3-oxo-2-(2-(2,2,2-trifluoroethoxy)phenyl)-2,3-dihydropyridazine-4-carboxamide
G43-C3-TEG
(2S,3R,4R,5S)-2-(Hydroxymethyl)-1-pentylpiperidine-3,4,5-triol
Ibiglustat succinate
Glucosylceramide synthase-IN-3
(2S,3R,4R,5S)-1-(5-((2-Fluoro-[1,1'-biphenyl]-4-yl)methoxy)pentyl)-2-(hydroxymethyl)piperidine-3,4,5-triol
(S)-Quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate (S)-2-hydroxysuccinate
(2R,3R,4R,5S)-1-(Butyl-d9)-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride
